How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TEMPLE UNIVERSITY HEALTH SYSTEM, INC. · Firm: HOLLAND & KNIGHT LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DENVER HEALTH AND HOSPITAL AUTHORITY via HOLLAND & KNIGHT LLP
2026 · third_quarter · 3A
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding; Administration for Strategic Preparedness and Response.
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; support for approval of Colorado provider tax.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
| RAYUS RADIOLOGY | 38 | 2014–2026 |
| Viatris Inc | 31 | 2020–2026 |
| BAYCARE HEALTH SYSTEM | 25 | 2013–2018 |
| FLORIDA HOSPITAL ASSOCIATION | 25 | 2013–2020 |
| ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS | 24 | 2021–2026 |
| TRIAD LIFE SCIENCES, INC. | 19 | 2022–2026 |
| DENVER HEALTH AND HOSPITAL AUTHORITY | 17 | 2018–2026 |
| OCHIN, INC | 16 | 2017–2021 |
| THE BIOSIMILARS FORUM | 15 | 2015–2018 |
| TRAUMA CENTER ASSOCIATION OF AMERICA | 15 | 2013–2016 |
| FRONT LINE HOSPITAL ALLIANCE | 13 | 2019–2022 |
| NATIONAL ASSOCIATION OF EMERGENCY MEDICAL TECHNICIANS | 12 | 2013–2015 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK | 11 | 2023–2025 |
| BLUE CROSS AND BLUE SHIELD OF MINNESOTA | 11 | 2014–2020 |
| 340B HEALTH (F/K/A SAFETY NET HOSPITALS FOR PHARMACEUTICAL ACCESS) | 10 | 2013–2015 |
| DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE | 10 | 2022–2024 |
| ATRIUS HEALTH, INC. | 9 | 2020–2022 |
| AMERICAN NEUROMONITORING ASSOCIATION | 8 | 2013–2015 |
| UC HEALTH | 8 | 2022–2024 |
| AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | 7 | 2018–2019 |
| DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) | 7 | 2025–2026 |
| LIFECELL CORPORATION | 7 | 2013–2014 |
| NOVO NORDISK, INC. | 7 | 2025–2026 |
| SCIPHER MEDICINE CORPORATION | 7 | 2022–2024 |
| ABRIDGE AI INC | 6 | 2025–2026 |
| AMERICAN ASSOCIATION OF POISON CONTROL CENTERS | 6 | 2013–2014 |
| DATAMOTION, INC. | 6 | 2022–2023 |
| SKINCURE ONCOLOGY | 6 | 2024–2025 |
| AMERICAN SOCIETY OF ANESTHESIOLOGISTS | 5 | 2025–2026 |
| DERMA SCIENCES, INC. | 5 | 2014 |
| DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS | 5 | 2025–2026 |
| EKATERRA TEA MSO USA, LLC DBA LIPTON TEAS & INFUSIONS | 5 | 2024 |
| ERLANGER HEALTH SYSTEM | 5 | 2014–2015 |
| MAXIMUM FIDELITY SURGICAL SIMULATIONS, LLC | 5 | 2017 |
| NORTHRUP GRUMMAN SYSTEMS CORPORATION | 5 | 2017 |
| COLOPLAST CORPORATION | 4 | 2026 |
| GAINWELL TECHNOLOGIES LLC | 4 | 2025 |
| GIVE LEGACY, INC. | 4 | 2022–2023 |
| INTERMEDIX CORPORATION | 4 | 2015–2016 |
| SHIRE PHARMACEUTICALS, INC | 4 | 2013–2014 |
| THOMSON REUTERS | 4 | 2014–2015 |
| USN OPCO, LLC D/B/A PANORAMIC HEALTH | 4 | 2023–2024 |
| ADVOCATES FOR EMS | 3 | 2013 |
| AN ACHIEVABLE DREAM ACADEMIES | 3 | 2021 |
| COUNTY OF DELAWARE, PA | 3 | 2021–2022 |
| HOLLISTER INCORPORATED | 3 | 2026 |
| LIFESPAN CORPORATION | 3 | 2018 |
| MAGNUM TRANSACTION SUB, LLC D/B/A LYRIC | 3 | 2025 |
| PRIDE MOBILITY PRODUCTS CORPORATION | 3 | 2020–2021 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | 3 | 2020 |
| VERSITI BLOOD HEALTH, INC. | 3 | 2026 |
| AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2 | 2026 |
| AMERICAN ACADEMY OF OTOLARYNGOLOGY - HEAD AND NECK SURGERY | 2 | 2026 |
| COMMUNITY CARE OF NORTH CAROLINA | 2 | 2013 |
| COOPERATIVE OF AMERICAN PHYSICIANS - MUTUAL PROTECTION TRUST (CAP-MPT) | 2 | 2020–2021 |
| ELEVATE ENT PARTNERS | 2 | 2026 |
| FPMCM, LLC D/B/A FAST PACE HEALTH | 2 | 2025 |
| GUIDEHOUSE LLP | 2 | 2026 |
| SOCIETY FOR HUMAN RESOURCES MANAGEMENT | 2 | 2026 |
| TELE-ACUTE AND CRITICAL CARE COALITION | 2 | 2013 |
| BLUEBIRD STRATEGIES | 1 | 2023 |
| METROHEALTH SYSTEM | 1 | 2026 |
Proposed 340B Rebate model; H.R. 1 - Medicaid implementation issues; substance abuse funding; H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Community Project Funding.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Skin Substitute Access and Payment Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Skin Substitute Access and Payment Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Skin Substitute Access and Payment Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Empowering Young Readers Act of 2026
Client: DENVER HEALTH AND HOSPITAL AUTHORITY · Firm: HOLLAND & KNIGHT LLP
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding.
Empowering Young Readers Act of 2026
Client: DENVER HEALTH AND HOSPITAL AUTHORITY · Firm: HOLLAND & KNIGHT LLP
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding; Administration for Strategic Preparedness and Response.
Empowering Young Readers Act of 2026
Client: DENVER HEALTH AND HOSPITAL AUTHORITY · Firm: HOLLAND & KNIGHT LLP
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding; Administration for Strategic Preparedness and Response.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: TEMPLE UNIVERSITY HEALTH SYSTEM, INC. · Firm: HOLLAND & KNIGHT LLP
Proposed 340B Rebate model; H.R. 1 - Medicaid implementation issues; substance abuse funding; H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Community Project Funding.
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; Drug Shortages; Medicaid Generics Penalty.
Skin Substitute Access and Payment Reform Act of 2025
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act of 2025
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Skin Substitute Access and Payment Reform Act of 2025
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act of 2025
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Skin Substitute Access and Payment Reform Act of 2025
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Skin Substitute Access and Payment Reform Act of 2025
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Medical Foods and Formulas Access Act of 2025
Client: UNITED MITOCHONDRIAL DISEASE FOUNDATION · Firm: HOLLAND & KNIGHT LLP
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
When Minutes Count for Emergency Medical Patients Act
Client: NATIONAL ASSOCIATION OF EMS PHYSICIANS · Firm: HOLLAND & KNIGHT LLP
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Skin Substitute Access and Payment Reform Act
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act (S. 2561 / H.R. 5768).
Skin Substitute Access and Payment Reform Act
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561/H.R. 5768).
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Increasing Transparency in Generic Drug Applications Act
Client: VIATRIS INC · Firm: HOLLAND & KNIGHT LLP
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Skin Substitute Access and Payment Reform Act of 2025
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561/H.R. 5768).
Skin Substitute Access and Payment Reform Act of 2025
Client: CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Firm: HOLLAND & KNIGHT LLP
Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act (S. 2561 / H.R. 5768).
Skin Substitute Access and Payment Reform Act of 2025
Client: DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS · Firm: HOLLAND & KNIGHT LLP
Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Treat and Reduce Obesity Act of 2021
Client: NOVO NORDISK, INC. · Firm: HOLLAND & KNIGHT LLP
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Access to Prescription Digital Therapeutics Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Access to Prescription Digital Therapeutics Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Access to Prescription Digital Therapeutics Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Access to Prescription Digital Therapeutics Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Access to Prescription Digital Therapeutics Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Strengthening Medicare for Patients and Providers Act
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Strengthening Medicare for Patients and Providers Act
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Strengthening Medicare for Patients and Providers Act
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Strengthening Medicare for Patients and Providers Act
Client: RAYUS RADIOLOGY · Firm: HOLLAND & KNIGHT LLP
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Medicaid VBPs for Patients Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
Support reform of Medicare physician reimbursement (H.R. 2474); support alternative payment models for radiology; support Find It Early Act (H.R. 3086); support continuation of appropriate use program under Section 218(b) of the Preserving Access to Medicare Act.
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Saving Organs One Flight at a Time Act
Client: ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS · Firm: HOLLAND & KNIGHT LLP
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Saving Organs One Flight at a Time Act
Client: ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS · Firm: HOLLAND & KNIGHT LLP
IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification.
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
CONNECT for Health Act of 2023
Client: DIGITAL HEALTH FOR EQUITABLE HEALTH ALLIANCE · Firm: HOLLAND & KNIGHT LLP
Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digital Therapeutics Act (S.3791/H.R. 1458).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
Accelerating Kids’ Access to Care Act
Client: ALLIANCE FOR REGENERATIVE MEDICINE · Firm: HOLLAND & KNIGHT LLP
CMS policies and federal legislation regarding Value Based payment legislation; Promote policies to support value based payment; Accelerating Kids Access to Care Act (S. 2372/ HR 4758); MVP Act (HR 2666).
DENVER HEALTH AND HOSPITAL AUTHORITY via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding; Administration for Strategic Preparedness and Response.
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; support for approval of Colorado provider tax.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Address negative impacts under HHS proposed 340B rebate pilot program; Support Community Project Funding in FY2027 Labor-HHS-Education appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Engagement with Centers for Medicare & Medicaid concerning supervision rule and potential changes to rule; Engagement with Veterans Administration regarding supervision rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Veterans Affairs, Dept of (VA)
GUIDEHOUSE LLP via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Department of Health & Human Services contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR HUMAN RESOURCES MANAGEMENT via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Federal affairs issues pertaining to workforce and labor issues impacting SHRM membership.
Filing targets: Commerce, Dept of (DOC), Health & Human Services, Dept of (HHS), Labor, Dept of (DOL)
HOLLISTER INCORPORATED via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COLOPLAST CORPORATION via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERSITI BLOOD HEALTH, INC. via HOLLAND & KNIGHT LLP
2026 · third_quarter · 3T
Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVATE ENT PARTNERS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
AMERICAN ACADEMY OF OTOLARYNGOLOGY - HEAD AND NECK SURGERY via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via HOLLAND & KNIGHT LLP
2026 · third_quarter · Q3
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via HOLLAND & KNIGHT LLP
2026 · third_quarter · RR
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
ELEVATE ENT PARTNERS via HOLLAND & KNIGHT LLP
2026 · third_quarter · RR
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
AMERICAN ACADEMY OF OTOLARYNGOLOGY - HEAD AND NECK SURGERY via HOLLAND & KNIGHT LLP
2026 · third_quarter · RR
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
Medicare Physician Fee Schedule (MPFS) CY 2027 proposed rule; global surgery payment policies; Modifier-25 payment reductions; physician reimbursement; Medicare payment policy; patient access; Centers for Medicare & Medicaid Services (CMS) physician payment regulations.
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Proposed 340B Rebate model; H.R. 1 - Medicaid implementation issues; substance abuse funding; H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Community Project Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR HUMAN RESOURCES MANAGEMENT via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Federal affairs issues pertaining to workforce and labor issues impacting SHRM membership.
Filing targets: Commerce, Dept of (DOC), Health & Human Services, Dept of (HHS), Labor, Dept of (DOL)
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERSITI BLOOD HEALTH, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HOLLISTER INCORPORATED via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLOPLAST CORPORATION via HOLLAND & KNIGHT LLP
2026 · second_quarter · 2A
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLOPLAST CORPORATION via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GUIDEHOUSE LLP via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Department of Health & Human Services contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) via HOLLAND & KNIGHT LLP
2026 · second_quarter · 2T
Coverage of radiation therapy treatments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DENVER HEALTH AND HOSPITAL AUTHORITY via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; support for approval of Colorado provider tax.
Designation of front line hospitals and recognizing uncompensated costs in hospital specific DSH limit; 340B Drug Discount Program; reintroduction on H.R. 7327 - Protecting Front Line Multimission Hospitals Act of 2024 in the 119th Congress; community project funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via HOLLAND & KNIGHT LLP
2026 · second_quarter · Q2
Engagement with Centers for Medicare & Medicaid concerning supervision rule and potential changes to rule; Engagement with Congress concerning provider reimbursement and Veterans Administration issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERSITI BLOOD HEALTH, INC. via HOLLAND & KNIGHT LLP
2026 · second_quarter · RR
Medicare Organ Procurement Organization Issues, FY 2027 IPPS proposals pertaining to organ cost reconciliation policies.
COLOPLAST CORPORATION via HOLLAND & KNIGHT LLP
2026 · second_quarter · RR
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
HOLLISTER INCORPORATED via HOLLAND & KNIGHT LLP
2026 · second_quarter · RR
Legislation and regulatory policy involving the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program and ostomy/urological supplies.
METROHEALTH SYSTEM via HOLLAND & KNIGHT LLP
2026 · second_quarter · RR
Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.
Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.
Support for inclusion of a study on military civilian partnerships for excellence; support for development of national trauma system as part of the Pandemic and All Hazards Act reauthorization; support for revising trauma activation fees to ensure appropriate trauma volume.
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health.
FY 2027 federal funding for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYUS RADIOLOGY via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services; support for appropriations language for Secretary of HHS to provide clarification of EMTALA on wall-time.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
S.2561/H.R. 5768 - Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Coverage of radiation therapy treatments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via HOLLAND & KNIGHT LLP
2026 · first_quarter · Q1
Engagement with Centers for Medicare & Medicaid concerning supervision rule and potential changes to rule; Engagement with Congress concerning provider reimbursement and Veterans Administration issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYUS RADIOLOGY via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · 4A
Modify legislation changing Section 203 of the Consolidated Appropriations Act 2020 (Medicaid DSH hospital specific limits).
FPMCM, LLC D/B/A FAST PACE HEALTH via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Educate regarding state proposals to expand care and services pursuant to the Rural Health Transformation Fund.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Modify legislation changing Section 203 of the Consolidated Appropriations Act 2020 (Medicaid DSH hospital specific limits).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOLIS MAMMOGRAPHY via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · 4T
Mammography screening access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act (S. 2561 / H.R. 5768).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561/H.R. 5768).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Coverage of radiation therapy treatments.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Engagement with Centers for Medicare & Medicaid concerning supervision rule and potential changes to rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · Q4
Support increased funding for cancer-related federal programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · RR
Engagement with Centers for Medicare & Medicaid concerning supervision rule and potential changes to rule.
DYNAMIC MEDICAL SERVICES D/B/A ACESSO BIOLOGICS via HOLLAND & KNIGHT LLP
2025 · fourth_quarter · RR
Medicare coverage of wound care therapies and the Skin Substitute Access and Payment Reform Act of 2025 (S.2561).
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Support increased funding for cancer-related federal programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAYUS RADIOLOGY via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Modify legislation changing Section 203 of the Consolidated Appropriations Act 2020 (Medicaid DSH hospital specific limits).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GAINWELL TECHNOLOGIES LLC via HOLLAND & KNIGHT LLP
2025 · third_quarter · 3T
Federal Employee Health Benefits (FEHB) Protection Act, Medicaid program integrity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Medicare coverage of wound care therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOLIS MAMMOGRAPHY via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Mammography screening access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DERMATOLOGY ASSOCIATION OF RADIATION THERAPY (DART) via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Coverage of radiation therapy treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Medicare Organ Procurement Organization Issues, General Organ Procurement Education, Organ Donor Referral bills and FAA issues related to organ donation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2025 · third_quarter · Q3
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABRIDGE AI, INC. via HOLLAND & KNIGHT LLP
2025 · third_quarter · RR
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
Artificial intelligence in health care; Medicare and Medicaid coverage and reimbursement of AI-assisted clinical documentation; CMS proposed payment policies; oversight of AI in health technology; implementation of transparency, privacy, and security standards for AI-enabled clinical decision support.
FPMCM, LLC D/B/A FAST PACE HEALTH via HOLLAND & KNIGHT LLP
2025 · third_quarter · RR
Pursuit of funding for the Rural Transformation Program.
VIATRIS INC via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2025 · second_quarter · 2A
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK, INC. via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
H.R. 1577 - Treat and Reduce Obesity Act of 2021 (117th Cong.).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Support increased funding for cancer-related federal programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF CRITICAL CARE TRANSPORT via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Implementation by the Administration of the No Surprises Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF EMS PHYSICIANS via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Development of legislation regarding reimbursement for medical directors and ambulance agencies; changing Medicare reimbursement regarding treatment in place; inquiring about finalization of DEA Rule for administration of emergency medications on ambulances; drug shortages; H.R.3443 - To amend title XI of the Social Security Act to create a model, and to direct the Medicare Payment Advisory Commission to carry out a study and report with respect to Medicare payment for emergency medical services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEMPLE UNIVERSITY HEALTH SYSTEM, INC. via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Modify legislation changing Section 203 of the Consolidated Appropriations Act 2020 (Medicaid DSH hospital specific limits). Support cancer research funding and Medicare reimbursement for dedicated cancer centers.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAGNUM TRANSACTION SUB, LLC D/B/A LYRIC via HOLLAND & KNIGHT LLP
2025 · second_quarter · 2T
Federal policies potentially impacting the utilization of technologies to streamline and expedite health care claims processing.
RAYUS RADIOLOGY via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Support inclusion of legislation relieving CY2026 cuts in Medicare physician reimbursement (H.R. 1 budget reconciliation); support legislation extending enhanced Medicare telehealth authorities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED MITOCHONDRIAL DISEASE FOUNDATION via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
FY 2026 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research); Medical Nutrition Act; Telehealth Authority extension.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Medicare coverage of wound care therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOLIS MAMMOGRAPHY via HOLLAND & KNIGHT LLP
2025 · second_quarter · Q2
Mammography screening access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE